From: Immune derangement occurs in patients with H7N9 avian influenza
Variables | Values |
---|---|
Age (years) | 62 ± 14 |
Male, n (%) | 16 (59.3) |
Smoker, n (%) | 8 (29.6) |
Exposure to live poultry, n (%) | 16 (59.3) |
Underlying conditions, n (%) | |
Any | 15 (55.6) |
Hypertension | 13 (48.1) |
Coronary heart disease | 2 (7.4) |
Diabetes mellitus | 3 (11.1) |
Chronic obstructive pulmonary disease | 1 (3.7) |
Other | 7 (25.9) |
Days between disease onset and admission | 1.0 (0.5 to 19.0) |
White blood cell count (109/L) | 5.1 ± 3.0 |
Hemoglobin (g/dl) | 123 ± 24 |
Platelet count (109/L) | 132 ± 46 |
Alanine aminotransferase (U/L) (n = 26) | 36 (12 to 262) |
Creatinine (μmol/L) | 57 (25 to 266) |
Potassium (mmol/L) | 4.37 ± 0.48 |
Sodium (mmol/L) | 139 ± 4 |
International normalized ratio | 1.08 ± 0.093 |
D-dimer (μg/L) (n = 26) | 2,790 (120 to 42,920) |
PaO2:FiO2 ratio | 143.26 ± 58.38 |
Chest radiological abnormalities | |
Involvement of both lungs (n = 26) | 18 (69.2) |
Ground-glass opacities (n = 21) | 2 (8.7) |
Pulmonary consolidation | 25 (92.6) |
APACHE II score | 22.26 ± 7.70 |
Complications | |
Acute respiratory distress syndrome, n (%) | 19 (70.4) |
Secondary infection, n (%) | 13 (48.1) |
Liver damage, n (%) (n = 26) | 12 (44.4) |
Shock, n (%) | 6 (22.2) |
Acute renal injury, n (%) | 1 (3.7) |
Antiviral therapy with oseltamivir, n (%) | 27 (100) |
Glucocorticoid therapy, n (%) | 10 (37.0) |
Mechanical ventilation, n (%) | 13 (48.1) |
Extracorporeal membrane oxygenation, n (%) | 9 (33.3) |